Cord blood mononuclear leukocytes of neonates at risk of atopy have a deficiency of arachidonic acid.

Essential fatty acids and their delta-6-desaturated derivatives are major components of cellular membrane phospholipids, contributing to their stability and functions. They are also precursors of inflammation mediators such as prostaglandins and leukotrienes, and are involved in cellular immunoregulation. Recent studies have stressed the importance of essential fatty acids in various diseases. Patients with atopic dermatitis have altered essential fatty acids levels in plasma and a clinical improvement has been shown after oral administration of essential fatty acids. The aim of our study was to investigate the distribution of essential fatty acids in the membranes of cord blood mononuclear leukocytes of newborns at risk of atopy, and to correlate the levels of essential fatty acids at birth with total IgE values and with the onset of atopic disease. Newborns at risk of atopic disease have a significant reduction in arachidonic acid in the membranes of cord blood mononuclear leukocytes. Our data show a significant decrease in arachidonic acid in neonates at risk of atopy, suggesting that the abnormality of essential fatty acids is a primary phenomenon associated with atopic status.

Breast milk from mothers of children with newly developed atopic eczema has low levels of long chain polyunsaturated fatty acids.

BACKGROUND: Infants at risk of atopic dermatitis have lower than normal levels of long chain polyunsaturated fatty acids. These fatty acids are normally present in substantial quantities in human breast milk. METHODS: Because of the equivocal evidence concerning the ability of breastfeeding to delay the onset or reduce the severity of atopic dermatitis, we have analyzed the fatty acid composition of breast milk from the mothers of children with newly developed disease with the use of gas chromatography. RESULTS: Breast milk lipids from mothers of children with newly developed atopic dermatitis had increased proportions of linoleic acid and significantly decreased proportions of its long chain polyunsaturated derivatives compared with a control group. The ratio of linoleic acid to the sum of its metabolites, gamma-linolenic acid, dihomo-gamma-linolenic acid, and arachidonic acid was 11.78 in the atopic group and 9.02 in the control group (p < 0.01). CONCLUSIONS: These results are consistent with previous findings of an abnormal fatty acid status in atopic subjects and may account for some of the inconsistent results from studies of the effect of breastfeeding on the subsequent development of atopic dermatitis. We conclude that further studies to examine the effects of supplementation of the diet of breastfeeding mothers with long chain polyunsaturates should be done.